Infectious disease diagnostics is used to identify the causative agent/microorganism of the infectious diseases. The global infectious disease diagnostics market was valued at $13.97 billion in 2017 and expected to reach $20.24 billion by 2025 with a CAGR of 5.94% during the forecast period from 2019-2025. The factors such as increasing prevalence of infectious diseases and shift in focus from centralised laboratories to decentralised Point-of-Care testing are fueling the market growth. The factors like rising health care costs limiting the use of novel diagnostic techniques & inadequate reimbursements are hindering the market growth. The growing awareness about personalised medicine & advances in genomics and proteomics are creating opportunities for market growth.

Research Study Objectives:

• Define, estimate, and forecast the Infectious Disease Diagnostics market statistics by product & service, technology, diseases type, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Infectious Disease Diagnostics market growth
• Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
• Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
• Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Infectious Disease Diagnostics Market Analysis
• Analysis and conclusions on the future Infectious Disease Diagnostics market outlook.

Top-down and bottom-up approaches are used to validate the Infectious Disease Diagnostics Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Infectious Disease Diagnostics Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Infectious Disease Diagnostics market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The Infectious Disease Diagnostics market segmentation is as follows:

By Product & Services

• Services & Software
• Assays, Kits, & Reagents
• Instruments
• Others

By Technology

• Clinical Microbiology
• Immunodiagnostics
• DNA Microarray
• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• DNA Sequencing & Next-Generation Sequencing (NGS)
• Others

By Diseases Type

• Influenza
• Tuberculosis (TB)
• Hospital-Acquired Infections (HAIS)
• Human Papillomavirus (HPV)
• Human Immunodeficiency Virus (HIV)
• Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
• Hepatitis
• Others

By End User

• Academic/Research Institutes
• Hospital/Clinical Laboratories
• Reference Laboratories
• Physician Offices
• Hospital/Clinical Laboratories
• Others

Geographical Analysis:

Infectious Disease Diagnostics Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Infectious Disease Diagnostics Market include:

• Scope Revision
• Geographic Analysis
• Company Profiles
• Historical Data & Forecasting
• Key Contact Persons in companies

Global Infectious Disease Diagnostics Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact on altering market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the significant Infectious Disease Diagnostics market players, such as
  • Agilent Technologies, Inc.
  • Roche Diagnostics, Pvt. Ltd.
  • Abbott Laboratories, Ltd.
  • Becton, Dickinson and Company
  • Danaher Corporation
• Along with these companies, many other companies are considered in the report while analysing the Global Infectious Disease Diagnostics competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.